<DOC>
	<DOCNO>NCT00813306</DOCNO>
	<brief_summary>The purpose study assess safety tolerability AZD2066 explore effect single dose AZD2066 function cardia ( open stomach esophagus ) compare placebo ( contain medical substance ) healthy volunteer .</brief_summary>
	<brief_title>14473 - D9126C00001 Proof Principle Study - Effect AZD2066 Transient Lower Esophageal Sphincter Relaxations</brief_title>
	<detailed_description />
	<criteria>Provision write consent prior study specific procedure . Healthy subject , age 1845 year inclusive . Females must childbearing potential must use highly effective contraceptive method . Clinically normal physical finding laboratory value time preentry visit , judge investigator . Clinically significant illness within 2 week prior first dose investigational product , include suspected/manifested infection accord WHO risk category 2 , 3 4 , judge investigator . A measured LES pressure &lt; 5mm Hg . History previous ongoing psychiatric disease/condition .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>December 2010</verification_date>
	<keyword>GERD</keyword>
	<keyword>TLESR</keyword>
	<keyword>reflux</keyword>
</DOC>